Sara Tolaney
Analyst
Analyst — External Investigator, Dana-Farber/Harvard
Earnings-call appearances
-
Phase 3 VIKTORIA-1 PIK3CA Mutant Cohort Clinical Trial Results Conference Call2026-06-02
Celcuity Inc. (CELC)